Mr. Dean Burns reports

OCUMETICS ANNOUNCES DECEMBER 20, 2023 WEBINAR REGARDING SUCCESSFUL COMPLETION OF ANIMAL STUDY

Ocumetics Technology Corp. will hold a webinar to discuss the successful completion of its biocompatibility animal study and its coming first-in-human study, anticipated to commence in Q1 2024 in the Dominican Republic.

Dean Burns, chief executive officer of Ocumetics and 27-year Alcon veteran, will lead the presentation.

Join the webinar to:

• Learn more about the significance of the biocompatibility animal study;
• Learn more about the coming first-in-human study;
• Ask questions regarding the Ocumetics accommodating lens and the company's plans.

Details are as follows:

• Date: Dec. 20, 2023;
• Time: 6 p.m. EST;
• RSVP: Ocumetics website.

About Ocumetics Technology Corp.

Ocumetics Technology, headquartered in Calgary, Alta., Canada, is an innovator in the field of ophthalmic technology, dedicated to developing and commercializing advanced vision correction solutions that enhance the quality of life for individuals worldwide.

Ocumetics is in the preclinical study stage of a game-changing technology for the ophthalmic industry. In its pursuit of a next-generation interocular lens solution, Ocumetics has developed the Ocumetics accommodating lens, an expandable intraocular lens that fits within the natural lens compartment of the eye potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to seamlessly shift focus from distance to intermediate to near.